Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Sep 28 1999
WASHINGTON, D.C. (Sept. 28, 1999) - The BiotechnologyIndustry Organization (BIO) announced today South Carolina has become the 26th state to form an...
Sep 23 1999
WASHINGTON, D.C. -- The Biotechnology Industry Organization (BIO) today applauded Sen. Orrin Hatch (R-Utah) for his introduction of the Medicare Patient Access...
Sep 23 1999
WASHINGTON, D.C. (Sept. 23, 1999) The Biotechnology Industry Organization (BIO) strongly opposed a bill introduced today by U.S. Rep. Sherrod Brown (D-Ohio),...
Sep 23 1999
WASHINGTON, D.C. (Sept. 23, 1999) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), today issued the following statement on the...
Sep 21 1999
"Biotech Works" Theme Will Attract 7,000 from Around the World WASHINGTON, D.C. (September 21, 1999) Boston will get its first opportunity to host...
Aug 20 1999
WASHINGTON, D.C. (August 20, 1999) --The Biotechnology Industry Organization (BIO) has launched its second series of radio ads aimed at focusing President...
Aug 12 1999
WASHINGTON (Aug. 12, 1999) -- An expert panel of university and independent researchers, entomologists and weed scientists is currently conducting studies to...
Aug 5 1999
Washington, D.C. (August 4, 1999) -- In response to a study by University of Arizona entomologists appearing in the scientific correspondence of the Aug. 5...
Aug 4 1999
WASHINGTON, D.C. (August 4, 1999) The Biotechnology Industry Organization (BIO) today applauded the U.S. House for its overwhelming approval of a bill that...


Biotechnology News

September 19, 2014

BURR RIDGE, Ill.--(BUSINESS WIRE)--Project management consulting firm IPM named Great Place to Work for fifth consecutive year.

September 19, 2014

INGELHEIM & TÜBINGEN, Germany--(BUSINESS WIRE)--Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy

September 19, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the European Commission has granted marketing authorization for Zydelig® (...

September 19, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries...